Skip to main content
. 2016 Apr 14;6:24090. doi: 10.1038/srep24090

Figure 7. HIV-1 protease inhibitors block HIV-1 recovery from latently infected J-Lat 8.4 cells.

Figure 7

(A–C), J-Lat cells were either left untreated or treated with anti-CD3-mAb (2 μg/ml) +rNef (100 ng/ml) (A), anti-CD28-mAb (2.67 μg/ml) +anti-CD3-mAb (2 μg/ml) (B) and SAHA (2.5 μM) (C) in the absence or presence of different PI and RTI compounds as indicated. The viral production was determined by measuring the level of p24 antigen using ELISA. Means ± s.d. (n = 6). Ctr: Control; L/R, lopinavir/ritonavir; ATV: atazanavir; FOS: fosamprenavir, ABC: abacavir; EFV: efavirenz.